Alcentra Capital (NASDAQ:ABDC) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Thursday, March 15th.
ABDC has been the subject of several other reports. UBS raised shares of Alcentra Capital from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 11th. Raymond James Financial raised shares of Alcentra Capital from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 11th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $12.00.
ABDC traded down $0.03 during trading on Thursday, reaching $7.16. 60,992 shares of the company traded hands, compared to its average volume of 143,911. Alcentra Capital has a 12-month low of $5.93 and a 12-month high of $14.73. The firm has a market cap of $102.14, a P/E ratio of 5.42 and a beta of 0.57.
Alcentra Capital (NASDAQ:ABDC) last posted its earnings results on Wednesday, March 14th. The asset manager reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Alcentra Capital had a negative net margin of 57.28% and a positive return on equity of 10.56%. The firm had revenue of $8.20 million during the quarter, compared to analyst estimates of $7.77 million. equities research analysts expect that Alcentra Capital will post 0.94 EPS for the current year.
In other news, insider Branko Krmpotic acquired 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 20th. The stock was purchased at an average cost of $6.15 per share, for a total transaction of $61,500.00. Following the completion of the acquisition, the insider now directly owns 14,000 shares of the company’s stock, valued at approximately $86,100. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders purchased 14,750 shares of company stock valued at $91,788 over the last 90 days. 4.96% of the stock is currently owned by corporate insiders.
A number of institutional investors have recently made changes to their positions in the business. Stilwell Value LLC bought a new position in Alcentra Capital in the fourth quarter worth about $8,701,000. Pacific Ridge Capital Partners LLC bought a new position in Alcentra Capital in the fourth quarter worth about $1,171,000. BlackRock Inc. grew its stake in shares of Alcentra Capital by 18.0% during the fourth quarter. BlackRock Inc. now owns 89,703 shares of the asset manager’s stock worth $753,000 after acquiring an additional 13,669 shares during the last quarter. Wasatch Advisors Inc. grew its stake in shares of Alcentra Capital by 151.5% during the fourth quarter. Wasatch Advisors Inc. now owns 85,813 shares of the asset manager’s stock worth $720,000 after acquiring an additional 51,689 shares during the last quarter. Finally, Bramshill Investments LLC purchased a new stake in shares of Alcentra Capital during the fourth quarter worth about $512,000. Institutional investors and hedge funds own 35.19% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/07/alcentra-capital-abdc-rating-lowered-to-hold-at-valuengine.html.
Alcentra Capital Company Profile
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.